Off the Scales: ‘meticulously reported’ rise of Ozempic

In 2024, the US Centers for Disease Control and Prevention published “what could well be the most important table in modern public health”, said Tom Whipple in The Times. For decades, American waistlines had been expanding “inexorably”. But the 2024 assessment of “how fat the country was” revealed a change: the “number of fat people was just a little bit lower than it had been”. No one was in any doubt as to why. In 2017, a Danish company, Novo Nordisk, had released a new diabetes medication called Ozempic...